Temozolomide downregulates P-glycoprotein expression in glioblastoma stem cells by interfering with the Wnt3a/glycogen synthase-3 kinase/ -catenin pathway

The DNA repair protein ALKBH2 mediates temozolomide resistance in human glioblastoma cells

(2012) Tor-Christian Aase Johannessen et al.   NEURO-ONCOLOGY

Glioma Stem Cells: Their Role in Chemoresistance

(2012) Ryosuke Yamada et al.   World Neurosurgery

FoxM1 Promotes β-Catenin Nuclear Localization and Controls Wnt Target-Gene Expression and Glioma Tumorigenesis

(2011) Nu Zhang et al.   CANCER CELL

The ABCG2 resistance network of glioblastoma

(2011) Anne-Marie Bleau et al.   CELL CYCLE

Chemoresistance of glioblastoma cancer stem cells - much more complex than expected

(2011) Dagmar Beier et al.   Molecular Cancer

Neural stem/progenitors and glioma stem-like cells have differential sensitivity to chemotherapy

(2011) X. Gong et al.   NEUROLOGY

Molecular targeting of glioblastoma: Drug discovery and therapies

(2011) Ren-Yuan Bai et al.   TRENDS IN MOLECULAR MEDICINE

Antigenic and Genotypic Similarity between Primary Glioblastomas and Their Derived Neurospheres

(2011) Valentina Caldera et al.   Journal of Oncology

PLAGL2 Regulates Wnt Signaling to Impede Differentiation in Neural Stem Cells and Gliomas

(2010) Hongwu Zheng et al.   CANCER CELL

 -Secretase Inhibitors Enhance Temozolomide Treatment of Human Gliomas by Inhibiting Neurosphere Repopulation and Xenograft Recurrence

(2010) C. A. Gilbert et al.   CANCER RESEARCH

Primary brain tumors, neural stem cell, and brain tumor cancer cells: Where is the link?

(2010) Isabelle Germano et al.   NEUROPHARMACOLOGY

Enhanced MDR1 Expression and Chemoresistance of Cancer Stem Cells Derived from Glioblastoma

(2009) Eiichi Nakai et al.   CANCER INVESTIGATION

Digoxin and ouabain increase the synthesis of cholesterol in human liver cells

(2009) I. Campia et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Flow Cytometry Analysis of Neural Differentiation Markers Expression in Human Glioblastomas May Predict Their Response to Chemotherapy

(2009) Vladimir Balik et al.   CELLULAR AND MOLECULAR NEUROBIOLOGY

Wnt/β-Catenin Signaling: Components, Mechanisms, and Diseases

(2009) Bryan T. MacDonald et al.   DEVELOPMENTAL CELL

Glioblastoma multiforme: a review of where we have been and where we are going

(2009) Cory Adamson et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

CD133+ and nestin+ tumor-initiating cells dominate in N29 and N32 experimental gliomas

(2009) Daniel Bexell et al.   INTERNATIONAL JOURNAL OF CANCER

Cytotoxic Effects of Temozolomide and Radiation are Additive- and Schedule-Dependent

(2009) Anthony J. Chalmers et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Highly infiltrative brain tumours show reduced chemosensitivity associated with a stem cell-like phenotype

(2009) T.-C. A. Johannessen et al.   NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY

The Wnt receptor FZD1 mediates chemoresistance in neuroblastoma through activation of the Wnt/β-catenin pathway

(2009) M Flahaut et al.   ONCOGENE

A MDR1 (ABCB1) gene single nucleotide polymorphism predicts outcome of temozolomide treatment in glioblastoma patients

(2008) M. Schaich et al.   ANNALS OF ONCOLOGY

CD133 identifies perivascular niches in grade II–IV astrocytomas

(2008) Karina Christensen et al.   JOURNAL OF NEURO-ONCOLOGY

New (alternative) temozolomide regimens for the treatment of glioma

(2008) Wolfgang Wick et al.   NEURO-ONCOLOGY

Glioma Stem Cells: A Midterm Exam

(2008) Charles D. Stiles et al.   NEURON

Gliotypic Neural Stem Cells Transiently Adopt Tumorigenic Properties During Normal Differentiation

(2008) Noah M. Walton et al.   STEM CELLS